2m 2m 2m 2m 2m 2m 2m
VYNE THERAP (VYNE)
NASDAQ
$0.65-$0.004 (-0.62%)
Price as of Jun 23, 2026 7:00 PM EDT- $21.7MMarket Cap
- -28.89%1-Year Change
- BiotechnologyIndustry
VYNE THERAP (VYNE)
$0.65-$0.004 (-0.62%)
VYNE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.65 | ||
Change | +$0.01 (+2.30%) | ||
Open | $0.64 | ||
High | $0.66 | ||
Low | $0.64 | ||
Previous Close | $0.64 | ||
Volume | 45,419 | ||
30-Day Average Volume | 118,397 | ||
1-Week Change | 4.50% | ||
1-Month Change | -3.19% | ||
1-Year Change | -28.89% | ||
3-Year Change | -86.54% | ||
5-Year Change | -98.99% | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $25.9M | ||
Market Cap | $21.7M | ||
Enterprise Value | -$2.9M | ||
Period: QTR TTM FY | |||
Revenue | $86,000.00 | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$4.1M | ||
EBIT | -$3.6M | ||
EBITDA | -$3.6M | ||
Net Working Capital | N/A | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -34 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue